The Investigation of Predicting Mortality and Morbidity in Patients Admitted to Intensive Care Unit With Thoracic Trauma Using Selected Biomarkers and Parameters
1 other identifier
observational
50
1 country
1
Brief Summary
This prospective study aimed to predict morbidity and mortality after thoracic trauma in intensive care unit evaluated clinical and biochemical data of 50 intensive care unit patients. The research examined demographic factors such as gender, age, and smoking status, trauma scoring systems like ISS and RTS as well as biomarkers such as Surfactant-d and oxygenation parameters including the ROX index, PaO₂/FiO₂ ratio and FiO₂.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2024
CompletedFirst Submitted
Initial submission to the registry
January 3, 2025
CompletedFirst Posted
Study publicly available on registry
April 16, 2025
CompletedApril 16, 2025
March 1, 2025
11 months
January 3, 2025
April 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Mortality Prediction Using ROX Index in Thoracic Trauma Patients
To evaluate the predictive ability of the ROX index (unit: cmH₂O/L/s) for mortality in thoracic trauma patients. ROX index values were recorded at 1st, 3rd, and 7th days of hospitalization using standard clinical monitoring and ventilatory support parameters. Trends were analyzed in relation to survival outcomes.
Measurements taken on day 1, day 3, and day 7 of hospitalization, following ICU admission.
Mortality Prediction Using SP-D Levels in Thoracic Trauma Patients
To assess the prognostic value of Surfactant Protein D (SP-D) levels (unit: ng/mL) for mortality prediction in thoracic trauma patients. SP-D levels were measured using an ELISA assay (Elabscience® Human Pulmonary Surfactant-associated Protein-D ELISA Kit) at 1st, 3rd, and 7th days to evaluate trends and correlations with survival outcomes.
Measurements taken on day 1, day 3, and day 7 of hospitalization, following ICU admission.
Secondary Outcomes (6)
Predictive Value of APACHE II Score in Mortality
Measurements taken on day 1, day 3, and day 7 of hospitalization.
Predictive Value of SOFA Score in Mortality
Measurements taken on day 1, day 3, and day 7 of hospitalization.
Predictive Value of TRISS Score in Mortality
Measurements taken on day 1, day 3, and day 7 of hospitalization.
Predictive Value of RTS Score in Mortality
Measurements taken on day 1, day 3, and day 7 of hospitalization.
CRP Levels and Mortality Prediction
Measurements taken on day 1, day 3, and day 7 of hospitalization.
- +1 more secondary outcomes
Other Outcomes (2)
NEU/LYM Ratio and Mortality Correlation
Measurements taken on day 1, day 3, and day 7 of hospitalization.
Glasgow Coma Scale (GCS) and Mortality Correlation
Measurements taken on day 1, day 3, and day 7 of hospitalization.
Study Arms (1)
thorax trauma patients
thorax trauma patients admitted to icu
Interventions
blood samples obtained for 3 different days, limited to 5cc
Eligibility Criteria
Patients with thoracic trauma admitted to icu
You may qualify if:
- Patients with thoracic trauma between the ages of 18-85
- Patients who have been monitored in intensive care for at least 1 week
You may not qualify if:
- Being outside the age range of 18-85
- Pregnant patients
- Patients whose intensive care follow-up lasted less than 1 week
- Patients who do not want to be included in the study
- Patients with a lung malignancy diagnosis before admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Suleyman Demirel University
Isparta, 32260, Turkey (Türkiye)
Related Publications (3)
Determann RM, Royakkers AA, Haitsma JJ, Zhang H, Slutsky AS, Ranieri VM, Schultz MJ. Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients. BMC Pulm Med. 2010 Feb 16;10:6. doi: 10.1186/1471-2466-10-6.
PMID: 20158912BACKGROUNDBaker JE, Millar DA, Heh V, Goodman MD, Pritts TA, Janowak CF. Does chest wall Organ Injury Scale (OIS) or Abbreviated Injury Scale (AIS) predict outcomes? An analysis of 16,000 consecutive rib fractures. Surgery. 2020 Jul;168(1):198-204. doi: 10.1016/j.surg.2020.04.032. Epub 2020 May 13.
PMID: 32507628BACKGROUNDLundin A, Akram SK, Berg L, Goransson KE, Enocson A. Thoracic injuries in trauma patients: epidemiology and its influence on mortality. Scand J Trauma Resusc Emerg Med. 2022 Dec 12;30(1):69. doi: 10.1186/s13049-022-01058-6.
PMID: 36503613BACKGROUND
Biospecimen
Hemogram Biochemical markers arterial blood gas analyses
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
pınar karabacak
Suleyman Demirel University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- RESEARCH ASSISTANT
Study Record Dates
First Submitted
January 3, 2025
First Posted
April 16, 2025
Study Start
April 15, 2023
Primary Completion
March 15, 2024
Study Completion
April 15, 2024
Last Updated
April 16, 2025
Record last verified: 2025-03